Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy

Overview of attention for article published in BMC Cancer, January 2014

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,447 followers.

Progression-free surv at 2y as a surrogate marker for the 5y surv rate in advanced NSCLC treated with ChRT http://t.co/JiqvTI2oIV #bmccancer

Progression-free surv at 2y as a surrogate marker for the 5y surv rate in advanced NSCLC treated with ChRT http://t.co/JiqvTI2oIV #bmccancer

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.